Exempts entities registered with the department of health and senior services that distribute hypodermic needles or syringes from the crime of unlawful delivery of drug paraphernalia
Summary
HB 1585 would create a state registration process for syringe access programs through the Missouri Department of Health and Senior Services. An entity could operate such a program if it meets department requirements, including having a collaborative agreement with an organization that provides access to mental health and substance use treatment options. The bill also bars registered syringe access programs from being located within 500 feet of a school building, unless the school was established after the program was already operating.
To implement that framework, the bill repeals and reenacts Missouri’s drug paraphernalia laws to exempt registered syringe access programs, and their staff, volunteers, and participants, from the offenses of unlawful delivery and unlawful manufacture of drug paraphernalia when they possess, distribute, deliver, or manufacture hypodermic needles or syringes in connection with the program. The underlying criminal penalties remain in place for other conduct, but the bill carves out a specific legal protection for authorized harm-reduction services.
Impact
HB 1585 would amend Missouri’s criminal code provisions in sections 579.040 and 579.076 and add a new section 191.1011 to the health statutes. Its practical effect is to legalize, under state registration and oversight, the distribution and related handling of hypodermic needles and syringes by syringe access programs that meet Department of Health and Senior Services requirements. It would also require the department to promulgate rules to administer the registration process and related standards, shifting these activities from potential criminal liability to a regulated public health framework.
Sentiment
Based on the bill text and caption, the measure appears to be framed as a public health and harm-reduction bill aimed at reducing risks associated with unsterile injection drug use. The available context does not include committee testimony or recorded votes, so there is no documented floor or committee sentiment to report. The structure of the bill suggests support for syringe access programs as a treatment-linked intervention, but the absence of voting history or transcripts limits assessment of broader legislative reaction.
Contention
The main point of contention is likely the policy choice to exempt syringe access programs from drug paraphernalia offenses, which may be viewed by opponents as facilitating drug use and by supporters as reducing disease transmission and connecting people to treatment. The bill also includes a school-buffer restriction, indicating sensitivity to concerns about program location and community impact. Another likely issue is the requirement for a collaborative agreement with mental health and substance use treatment providers, which may be seen as a safeguard by supporters but as an added administrative hurdle by program operators.